Regents of the University of California Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SRZNW
Surrozen Inc Warrant
SRZNW
|
+$3.05K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Blue Owl Capital
OBDC
|
+$34.4M |
| 2 |
Intellia Therapeutics
NTLA
|
+$2.63M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$2.33M |
| 4 |
Sana Biotechnology
SANA
|
+$853K |
| 5 |
Erasca
ERAS
|
+$558K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 99% |
| 2 | Communication Services | 0% |
| 3 | Healthcare | 0% |
Similar funds
Regents of the University of California's Q3 2024 Portfolio in Review
As of Q3 2024, Regents of the University of California held 8 positions worth $156M, down 15% from $183M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Regents of the University of California withdrew a net $41.1M in Q3 2024, closing 6 positions. Its most notable exit was Blue Owl Capital, an estimated $34.4M position sold in full.
By sector, the portfolio is most concentrated in Financials at 99% of assets, up from 98% a quarter earlier, followed by Communication Services and Healthcare.
Against the trend, Regents of the University of California opened a new position in Surrozen Inc Warrant worth $1.57M.
- Regents of the University of California's largest Q3 2024 buy was Surrozen Inc Warrant: 216,540 shares worth $1.57M.
- Regents of the University of California fully exited Blue Owl Capital in Q3 2024, selling an estimated $34.4M.
- Regents of the University of California's ten largest holdings make up 100% of its $156M portfolio in Q3 2024.
- Regents of the University of California opened 1 new position and closed 6 in Q3 2024.
- Regents of the University of California's portfolio value fell 15% quarter-over-quarter to $156M.
Based on Regents of the University of California's 13F filing for Q3 2024, filed 12 Nov 2024.